Adaptive Biotechnologies (ADPT.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Nov25

Adaptive Biotechnologies Corp Officer Sharon Benzeno Sells 606,402 Shares

02:47

Nov24

Adaptive Biotechnologies Corporation to Present 89 Abstracts on ClonoSEQ MRD Detection at ASH Annual Meeting

12:30

Nov6

Analysts at Craig-Hallum and TD Cowen Maintain Buy Rating on Adaptive Biotechnologies

16:03

Adaptive Biotechnologies released FY2025 Q3 earnings on November 5 After-Market (EST), actual revenue USD 93.97 M (forecast USD 64.65 M), actual EPS USD 0.0599 (forecast USD -0.1383)

00:00

Adaptive Biotechnologies released FY2025 9 Months Earnings on November 5 After-Market EST, with actual revenue of USD 205.3 M and EPS of USD -0.3085

00:00

Oct29

Adaptive Biotechnologies to Release FY2025 Q3 Earnings on November 5 After-Market (EST), Forecast Revenue USD 64.65 M, EPS USD -0.1383

00:28

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 93.97 M, Net Income 9.546 M, EPS 0.0599

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 58.88 M, Net Income -25.61 M, EPS -0.1684

May1

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 52.44 M, Net Income -29.85 M, EPS -0.2

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change